Sponsor:
Vanderbilt University Medical Center
Code:
NCT06930976
Conditions
Glucose
Metabolism
Isotope Labeling
Immune System and Related Disorders
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
13C6-Glucose
Brief summary:
Conditions
Glucose
Metabolism
Isotope Labeling
Immune System and Related Disorders
Study ID
NCT06930976
Start date
Oct 1, 2025
Status verified date
Oct, 2025
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Jun 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
12 participants
Anticipated
Intervention Model
Single group
Primary purpose
Basic Science
Arms
other: 13C6-Glucose
Interventions
13C6-Glucose
Primary outcome measure
Central contacts
Locations
Vanderbilt University Medical Center
Recruiting
Nashville, Tennessee, United States, 37212
Sponsor
Vanderbilt University Medical Center
Last update posted
Nov 4, 2025
Last verified
Oct, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2025-11-04.